公开(公告)号：US20220386951A1

公开(公告)日：2022-12-08

申请号：US17581028

申请日：2022-01-21

Applicant: MASIMO CORPORATION

Inventor： Jerome J. Novak, Jr.

IPC: A61B5/00 ,  A61B5/021 ,  A61M5/168 ,  G16H20/17 ,  G16H40/20 ,  G16H50/20 ,  A61M5/14 ,  G16H40/63 ,  G16H50/50 ,  A61M5/142 ,  A61M5/172 ,  G16H40/67

Abstract: An autonomous drug delivery system advantageously utilizes physiological monitor outputs so as to automatically give a bolus of a rescue drug or other necessary medication when certain criteria and confidence levels are met. An emergency button is provided to manually trigger administration of the rescue drug. The rescue drug may be an opioid antagonist in response to an analgesia overdose, a hypotensive drug to avert an excessive drop in blood pressure or an anti-arrhythmia drug to suppress abnormal heartbeats, to name a few.

公开(公告)号：US11504058B1

公开(公告)日：2022-11-22

申请号：US15824983

申请日：2017-11-28

Applicant: Masimo Corporation

Inventor： Vikrant Sharma ,  Philip Perea ,  Prashanth Iyengar

IPC: A61B5/00 ,  A61B5/0205 ,  A61B5/145 ,  A61B5/024 ,  A61B5/1455

Abstract: A patient monitor can noninvasively measure a physiological parameter using sensor data from different measurement sites on a patient. The patient monitor can combine all sensor data from different measurement sites into a raw or minimally processed data form to generate a single, robust measurement of the physiological parameter. An optical sensor of a patient monitor can include multiple photodetectors each configured to generate a signal when detecting light attenuated by the patient's tissue. A measurement of a physiological parameter can be determined based on at least in part on the multiple signals from the multiple photodetectors.

公开(公告)号：US11484230B2

公开(公告)日：2022-11-01

申请号：US17410944

申请日：2021-08-24

Applicant: Masimo Corporation

Inventor： Jeroen Poeze ,  Marcelo Lamego ,  Sean Merritt ,  Cristiano Dalvi ,  Hung Vo ,  Johannes Bruinsma ,  Ferdyan Lesmana ,  Massi Joe E. Kiani

IPC: A61B5/1455 ,  A61B5/145 ,  A61B5/00 ,  A61B5/024

Abstract: The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.

公开(公告)号：US20220330900A1

公开(公告)日：2022-10-20

申请号：US17587551

申请日：2022-01-28

Applicant: Masimo Corporation

Inventor： Ammar Al-Ali

IPC: A61B5/00 ,  A61B5/026 ,  A61B5/1455 ,  A61B5/0205 ,  A61B5/0295

Abstract: A perfusion trend indicator inputs a plethysmograph waveform having pulses corresponding to pulsatile blood flow within a tissue site. Perfusion values are derived corresponding to the pulses. Time windows are defined corresponding to the perfusion values. Representative perfusion values are defined corresponding to the time windows. A perfusion trend is calculated according to differences between representative perfusion values of adjacent ones of the time windows.

公开(公告)号：US11426105B2

公开(公告)日：2022-08-30

申请号：US16444960

申请日：2019-06-18

Applicant: Masimo Corporation

Inventor： Samuel Reichgott ,  Walter J. Shakespeare ,  George Kechter ,  Phillip William Wallace ,  Matthew J. Schurman

IPC: A61B5/1455 ,  A61B5/00 ,  A61B5/026 ,  A61B5/145

Abstract: Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis.

公开(公告)号：US20220248984A1

公开(公告)日：2022-08-11

申请号：US17659986

申请日：2022-04-20

Applicant: Masimo Corporation

Inventor： Jeroen Poeze ,  Marcelo Lamego ,  Sean Merritt ,  Cristiano Dalvi ,  Hung Vo ,  Johannes Bruinsma ,  Ferdyan Lesmana ,  Massi Joe E. Kiani

IPC: A61B5/1455 ,  A61B5/145 ,  A61B5/00 ,  A61B5/024

Abstract: The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.

公开(公告)号：US20220225938A1

公开(公告)日：2022-07-21

申请号：US17576859

申请日：2022-01-14

Applicant: MASIMO CORPORATION

Inventor： Ryan Timothy McHale ,  Walter M. Weber

IPC: A61B5/00 ,  A61B5/1455

Abstract: An embodiment of the present disclosure seeks to select characteristics of incoming intensity data that cause comparisons of selected characteristics to produce defined probe off space having reduced crossover with defined probe on space. Once defined, the present disclosure compares characteristics of incoming intensity data with the now defined probe off space, and in some embodiments, defined probe on space, to determine whether a probe off condition exists. When a processor determines a probe off condition exists, the processor may output or trigger an output signal that audibly and/or visually indicates to a user that the optical sensor should be adjusted for a proper application to a measurement site.

公开(公告)号：US20220218291A1

公开(公告)日：2022-07-14

申请号：US17581566

申请日：2022-01-21

Applicant: MASIMO CORPORATION

Inventor： Ammar Al-Ali ,  John Graybeal ,  Massi Joe E. Kiani ,  Michael Petterson ,  Chris Kilpatrick

IPC: A61B5/00 ,  A61B5/08 ,  A61B5/1455 ,  G16H50/30 ,  G16H40/63 ,  A61B5/318 ,  A61B5/0205 ,  A61B5/01 ,  A61B5/021 ,  A61B5/024 ,  A61B5/145

Abstract: An optical based patient monitoring system employing an optical sensor and providing an indication of an optical change which does not correlate to a change in a physiological blood parameter and based on that indication, providing a care provider an indication of a condition of a patient. The optical based patient monitoring system providing the indication of the patient condition in relation to a patient using an IV setup.

公开(公告)号：US20220216645A1

公开(公告)日：2022-07-07

申请号：US17403633

申请日：2021-08-16

Applicant: Masimo Corporation

Inventor： Ammar Al-Ali ,  Kevin Forrest ,  Yassir Kamel Abdul-Hafiz

IPC: H01R13/52 ,  A61B5/30

Abstract: Systems and methods are provided for water resistant connectors. A male connector includes a rib or a draft angle that creates a seal when engaged with a female connector. A male connector includes an overmold that includes or is made of a thermoplastic elastomer. Male or female connectors include molds that include or are made of a thermoplastic polymer, such as polypropylene. A female connector includes spring contacts that fit within individual pockets of the female connector.

公开(公告)号：US11331043B2

公开(公告)日：2022-05-17

申请号：US16377772

申请日：2019-04-08

Applicant: MASIMO CORPORATION

Inventor： Yassir Abdul-Hafiz ,  Ammar Al-Ali ,  Kevin Forrest ,  Eugene Mason ,  John Schmidt ,  Virginia Thanh Ta

IPC: A61B5/1455 ,  A61B5/00 ,  A61B5/0205 ,  A61B5/024 ,  A61B5/026

Abstract: An physiological measurement device provides a device body having a base, legs extending from the base and an optical housing disposed at ends of the legs opposite the base. An optical assembly is disposed in the housing. The device body is flexed so as to position the housing over a tissue site. The device body is unflexed so as to attach the housing to the tissue site and position the optical assembly to illuminate the tissue site. The optical assembly is configured to transmit optical radiation into tissue site tissue and receive the optical radiation after attenuation by pulsatile blood flow within the tissue.